参考文献/References:
[1]Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesth,2015,28(3):275-284.
[2]Savinkina AA, Haass KA, Sapiano MRP. Transfusionassociated adverse events and implementation of blood safety measuresfindings from the 2017 National Blood Collection and Utilization Survey. Transfusion,2020, 60(2):10-16.
[3]Anonymous. Practice guidelines for obstetric anesthesia:an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology,2016,90(2):600-611.
[4]Scott AV, Nagababu E, Johnson DJ. 2,3Diphosphoglycerate concentrations in autologous salvaged versus stored red blood cells and in surgical patients after transfusion. Anesth Analg,2016,122(3):616-623.
[5]DeAndrade D, Waters JH, Triulzi DJ. Very low rate of patientrelated adverse events associated with the use of intraoperative cell salvage. Transfusion,2016,56(11):2768-2772.
[6]Sullivan IJ, Ralph CJ. Obstetric intraoperative cell salvage: a review of an established cell salvage service with 1170 reinfused cases. Anaesthesia,2019,74(8):976-983.
[7]Pervez S, Katherine S, Brendan C. Amniotic fluid embolism: update and review.Curr Opin Anesthesiol,2016,29(3):288-296.
[8]Campbell JP, Mackenzie MJ, Yentis SM. An evaluation of the ability of leucocyte depletion filters to remove components of amniotic fluid. Anaesthesia,2012,67(10):1152-1157.
[9]Khan KS,Moore PA,Wilson MJ. Cell salvage and donor blood transfusion duringcesarean section: a pragmatic,multicentre randomised controlled trial. PLoS Med,2017,14(12):12-18.
[10]Grace L, Eleni K, Jamie MZ. Cell salvage for postpartum haemorrhage during vaginal delivery: a case series. Blood Transfus,2018,16(6):498-501.
[11]赵扬玉.以羊水栓塞发病机制为基础探讨其救治思路.实用妇产科杂志,2019,35(1):11-13.
[12]Oei SG, Wingen CBM, Kerkkamp HE. Cell salvage: how safe in obstetrics? Int J Obstet Anesth,2000,9(7):143-147.
[13]Greenawalt JA, Zernell D. Autologous blood transfusion for postpartum hemorrhage.MCN Am J Matern Child Nurs,2017,42(5):269-275.
[14]Locher MC, Sailer HF. The use of the Cell Saver in transoral maxillofacial surgery: a preliminary report. Craniomaxillofac Surg,1992,20(1):14-17.
[15]Kudo H, Fujita H, Hanada Y. Cytological and bacteriological studies of intraoperative autologous blood in neurosurgery. Surg Neurol,2004,62(3):195-199.
[16]Waters JH, Biscoti C, Poter PS. Amniotic fluid removal duringcell salvage in the cesarean section patient. Anesthesiology,2000,92(6):1531-1536.
[17]Teare KM, Sulivan IJ, Ralph CJ. Is cell salvaged vaginal blood loss suitable for reinfusion? Int J Obstet Anesth,2015,24(2):103-110.
[18]Waters JR, Meier HH, Waters JH. An economic analysis of costs associated with development of a cell salvage program. Anesth Analg,2007,104(4):869-875.
[19]Rebarber R, Lonser SJ. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol,1998,179(3):715-720.
[20]Huang J, Qin D, Gu C. Autologous and nonautologous blood transfusion in patients with ruptured ectopic pregnancy and severe blood loss. Biomed Res Int,2017,17(7):1-9.
[21]易宗平，高进，陈萍，等.血栓弹力图用于剖宫产术中凝血监测及预测出血量的临床研究.实用妇产科杂志,2018,34(4):277-281.
[22]Maya SS, Scott BS, Roanne LP. Shnider and Levinson’s Anesthesia for Obstetrics.Philadelphia:Lippincott Williams & Wilkins,2018.475.
[23]Grainger H, Catling S. Intraoperative cell salvage in obstetrics. J Perioper Pract,2018,28(3):51-58.
[24]Sullivan IJ,Ralph CJ. Obstetric intraoperative cell salvage and maternal fetal red cell contamination. Transfus Med,2018,28(4):298-303.
[25]Goucher H, Wong CA, Patel SK. Cell salvage in obstetrics. Anesth Analg,2015,121(2):465-468.
[26]Milne ME, Yazer MH, Waters JH. Red blood cell salvage during obstetric hemorrhage. Obstet Gynecol,2015,125(4):919-923.
[27]Albright CM, Rouse DJ, Werner EF. Cost savings of red cell salvage during cesarean delivery. Obstet Gynecol,2014,124(4):690-696.